Antibiotics are one of the great discoveries in medicine and the most important weapon in fighting bacterial diseases.
AHA Stat Blog
Latest
A new coalition of consumer advocates, employers and others today announced their opposition to the proposed health insurance deals between Aetna/Humana and Anthem/Cigna. The
Antibiotic resistance – when bacteria stop responding to the drugs designed to kill them – may be the single most important infectious disease threat of our time.
America’s hospitals honor the service of our nation’s veterans and work to provide high-quality care for those who have served in the armed forces. Working closely with our partners in the Veteran
There is a little-known – but critical – law that helps ensure hospitals are able to care for their communities. It is a ban on physician self-referral to hospitals in which they have an ownership
Saving an estimated 50,000 lives and $12 billion in health care costs is something to celebrate. Congratulations to the 3,700 acute-care hospitals that have participated in one of the Hospital Eng
The AHA is proud to support National Apprenticeship Week, November 2-6, sponsored by the Department of Labor (DOL).
Open enrollment in the Health Insurance Marketplace has begun and hospitals are geared up to continue the important work of making the enrollment process easy, accessible and widely available. Now
A July 6 Government Accountability Office (GAO) report examining Medicare Part B spending at hospitals participating in the 340B Drug Pricing Program draws unsubstantiated conclusions about a program that has a proven track record of improving access to care for poor patients and vulnerable communities. Simply put, the GAO report misses the mark.
A report paid for by a group backed by the pharmaceutical industry is the latest in a series of attempts to misrepresent a program that has a proven track record of helping poor patients and vulnerable communities.
A new report ;by the Berkley Research Group (BRG) is the latest attempt by the pharmaceutical industry to disparage a program with a proven track record of helping poor patients and vulnerable communities.
The 340B program accounts for only two percent of the $325 billion in annual drug purchases made in the U.S., or roughly $6.5 billion. Hospitals participating in the 340B program provided $28.4 billion in uncompensated care in 2012; in other words, four times the drug purchase amount.